Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor-Reference-Cited by-同舟云学术

Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor

Published:2015-02-27 Issue:5 Volume:75 Page:887-895
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Papadopoulos Kyriakos P.,Isaacs Randi,Bilic Sanela,Kentsch Kerstin,Huet Heather A.,Hofmann Matthias,Rasco Drew,Kundamal Nicole,Tang Zhongwhen,Cooksey Jennifer,Mahipal Amit

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2712-0.pdf

Reference36 articles.

1. Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55:178–194

2. Ashkenazi A (2002) Targeting death and decoy receptors or the tumor-necrosis factor superfamily. Nat Rev Cancer 2:420–430

3. Pan G, O’Rourke K, Chinnaiyan AM et al (1997) The receptor for the cytotoxic ligand TRAIL. Science 276:111–113

4. Roth W, Isenmann S, Naumann U et al (1999) Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun 265:479–483

5. Mitsiades CS, Treon SP, Mitsiades N et al (2001) TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. Blood 98:795–804

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-02

2. Targeting Death Receptor 5 (DR5) for imaging and treatment of primary bone and soft tissue tumors: an update of the literature;Frontiers in Molecular Biosciences;2024-09-02

3. Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research;Frontiers in Immunology;2024-08-22

4. Collapsed Star Copolymers Exhibiting Near Perfect Mimicry of the Therapeutic Protein “TRAIL”;Journal of the American Chemical Society;2024-07-26

5. Targeting apoptotic pathways for cancer therapy;Journal of Clinical Investigation;2024-07-15